Select Page

Independent. Trusted. Credible.


Industry collaboration for Australia’s genomics future

What's newGet involved



InGeNA is a single voice for Australian industry partners contributing to the rapidly developing field of genomics.

Alliance partners share a vision for Australia’s leadership in the adoption of genomics in healthcare.
– Better health outcomes
– Healthcare value and affordability
– A trusted, equitable and ethical genomics ecosystem

Collaboration across the key sectors of diagnostics/pathology, tech and pharma will ensure long and far-reaching benefits for Australian health consumers.

InGeNA the industry voice for the future of genomics in Australia

Who we are

InGeNA was formed by a group of industry organisations, hosted by the Australasian Institute of Digital Health (AIDH), to bring a shared perspective on critically important areas underpinning the future of genomics.

  • A patient-centred approach
  • Digital infrastructure & principles
  • Workforce planning & skills
  • Government policy making

VISION Realising the full potential of genomics to personalise healthcare

MISSION To harness the collective skills and expertise of industry to integrate genomics into healthcare

Stay connected, stay informed! We welcome your interest. Complete this form to sign up for regular news, events and updates.



Collaborative projects


All InGeNA projects are jointly funded by the Government’s MTPConnect, charged with driving innovation and growth in the medical technology, biotechnology and pharmaceutical sector. MTPConnect kickstarts collaborative, industry-led projects through a dollar-for-dollar matched Project Fund Program.

Chair Message

“We want Australians to have equity and access to the best that genomics can offer, now and in the future. With industry collaboration through InGeNA, there will be a single voice to have input into strategic planning, governance and funding directions through government, research centres and consumer health.”

David Bunker
InGeNA Chair


InGeNA News

InGeNA supporting Rare Disease Day 2021

InGeNA supporting Rare Disease Day 2021

300 million people living with a rare disease worldwide Over 6000 different rare diseases 72% of rare diseases are genetic On Rare Disease Day, Sunday 28 February, InGeNA is proud to support the global movement to raise public awareness of rare diseases...

read more
Media Statement

Media Statement

The genomics industry has formed a new alliance to strengthen collaboration, coordinate on key issues and realise opportunities for all Australians to benefit from precision healthcare.

read more

Genomics technology

The promise of genomics is to help Australians live longer and healthier lives by integrating genomics into the management of health and integrating genomics information and workflows into the health system.

The current focus of genomics is on using individual genetic information to inform tailored healthcare decisions.

Genomics is also expected to have a large impact at the population level in the future. Genomics has the potential to enable earlier diagnosis, improve the identification of the best treatment for the patient, and assist in disease prevention by analysing many genes or the entire genome (comprising all 22,000 genes present in human DNA) at once.




Contact Us


Level 1, 85 Buckhurst Street,
South Melbourne VIC 3205, Australia